| Aveo Pharmaceuticals Files To Sell Up To $86.3M In IPO - Wall Street Journal |
|
|
Wall Street JournalAveo launched a Phase III trial this month of tivozanib in patients with advanced renal cell cancer. Proceeds also will go to support research and ... read more |